[1] |
Kim J,Eisenberg D,Azagury D, et al. American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery[J]. Surgery for Obesity & Related Diseases Official Journal of the American Society for Bariatric Surgery, 2015, 12(3):453-459.
|
[2] |
Melissas J,Stavroulakis K,Tzikoulis V, et al. Sleeve Gastrectomy vs. Roux-en-Y Gastric Bypass. Data from IFSO-European Chapter Center of Excellence Program[J]. Obes Surg. 2017, 27(4):847-855.
|
[3] |
上海市医学会普外科分会减重代谢外科学组.上海市减重代谢手术年度报告及趋势分析(2012-2016)[J].中国实用外科杂志, 2018, 38(1):94-96.
|
[4] |
Li J,Lai D,Wu D. Laparoscopic Roux-en-Y gastric bypass vs. laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis[J]. Obes Surg, 2016, 26(2):429-442.
|
[5] |
Shoar S,Saber AA. Long-term and midterm outcomes of laparoscopic sleeve gastrectomy vs. Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies[J]. Surg Obes Relat Dis, 2017, 13(2):170-180.
|
[6] |
Wang MC,Guo XH,Zhang YW, et al. Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for obese patients with type 2 diabetes: a meta-analysis of randomized controlled trials[J]. Am Surg, 2015, 81(2):166-171.
|
[7] |
Osland E,Yunus RM,Khan S, et al. Diabetes improvement and resolution following laparoscopic vertical sleeve gastrectomy (LVSG) vs. laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a systematic review of randomized controlled trials[J]. Surg Endosc, 2017, 31 (4):1952-1963.
|
[8] |
Peterli R,Wölnerhanssen BK,Peters T, et al. Effect of Laparoscopic Sleeve Gastrectomy vs. Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial[J]. Jama the Journal of the American Medical Association, 2018, 319(3):255-265.
|
[9] |
Salminen P,Helmiö M,Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs. laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial[J]. JAMA. 2018;319(3):241-254.
|
[10] |
Courcoulas AP,Christian NJ,O’Rourke RW, et al. Preoperative factors and 3-year weight change in the Longitudinal Assessment of Bariatric Surgery (LABS) consortium[J]. Surg Obes Relat Dis, 2015, 11(5):1109-1118.
|
[11] |
BatterhamRL,Cummings DE. Mechanismsof diabetes improvement following bariatric/metabolic surgery[J]. Diabetes Care, 2016, 39(6):893-901.
|
[12] |
Gagner M,Hutchinson C,Rosenthal R. Fifth International Consensus Conference: current status of sleeve gastrectomy[J]. Surg Obes Relat Dis, 2016, 12(4):750-756.
|
[13] |
Stenberg E,Szabo E,Ågren G, et al. Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial[J]. Lancet, 2016, 387(10026):1397-1404.
|
[14] |
Stenberg E,Szabo E,Ottosson J,Näslund I. Outcomes of laparoscopic gastric bypass in a randomized clinical trial compared with a concurrent national database[J]. Br J Surg, 2017, 104(5):562-569.
|